How the 2026 Midterm Elections Could Move Markets: Sector-by-Sector Setup

Midterm elections don't move markets because of who wins — they move markets because of uncertainty about who wins, and what a change in the balance of power might mean for taxes, regulation, spending, and trade policy. That uncertainty tends to compress in the weeks immediately before the vote and resolve sharply once results are known, which is why the pattern in the data isn't "midterms are bad for stocks" so much as "midterms concentrate volatility into a shorter window than usual."

• Since 1950, the S&P 500 has averaged a below-trend return in the two quarters leading into a midterm election, historically the weakest stretch of the four-year presidential cycle
• That same data shows the twelve months following a midterm election have historically been the strongest stretch of the cycle, regardless of which party gained seats
• The pattern is best explained by uncertainty discount-and-release: markets price in policy risk ahead of the vote, then re-rate once the outcome and its practical limits become clear
• Divided government outcomes (different parties controlling the White House, House, and Senate) have historically coincided with steadier — not necessarily higher — returns, because gridlock reduces the odds of major policy shocks in either direction

The 2018 line is the one worth studying closely: a sharp Q4 selloff (driven mostly by Fed tightening fears, not the election itself) was followed by one of the strongest post-midterm rallies on record. It's a useful reminder that whatever is driving near-term volatility around a midterm — rate policy, trade tensions, a government funding fight — usually matters more than the election outcome itself.

Defense spending is set through annual appropriations bills that require some level of bipartisan support regardless of which party controls Congress, which is why defense contractors (Lockheed Martin, RTX, Northrop Grumman, General Dynamics) have historically been less sensitive to election outcomes than most other policy-linked sectors. The bigger near-term risk isn't the midterm result — it's whether a contentious post-election lame-duck session produces a continuing resolution, a full-year budget, or a shutdown fight that delays contract awards.

• Divided government has historically been a mild net positive for large-cap defense primes, since neither party has pushed for major cuts to core procurement budgets in recent cycles
• Government shutdown risk clusters around the fiscal year-end (September 30) and any post-midterm funding deadline — a more reliable near-term volatility driver than the vote itself
• Global conflict-driven demand (munitions replenishment, allied procurement) has been a larger swing factor for defense order books than domestic election outcomes in recent years

Healthcare and pharmaceutical stocks have historically been among the most election-sensitive names on the board, because drug pricing policy, Medicare negotiation authority, and ACA subsidy extensions are all decided legislatively — meaning which party controls the House and Senate directly changes what's achievable. Managed-care insurers (UnitedHealth, Elevance, Humana) and pharmaceutical manufacturers (Pfizer, Merck, Eli Lilly) tend to trade on different parts of this same policy axis.

• Expanded Medicare drug-price negotiation authority is the single biggest legislative swing factor for large pharma manufacturers heading into this cycle
• ACA marketplace subsidy extensions, last renewed on a temporary basis, are due for another decision point that directly affects managed-care insurer enrollment economics
• Biosimilar and PBM (pharmacy benefit manager) reform have drawn rare bipartisan interest, making them a policy risk that doesn't cleanly split along party-control lines
• Historically, gridlock (divided government) has been the best outcome for pharma multiples specifically, since it lowers the odds of aggressive price-control legislation passing in either direction

Oil and gas prices are set globally and are barely affected by U.S. domestic elections in the near term, but the regulatory environment for permitting, federal land leasing, and pipeline approvals genuinely does shift with control of Congress and, more directly, with the executive branch's agency leadership. Renewable energy developers face a mirror-image version of this same sensitivity through tax-credit policy (investment and production tax credits) that has been a recurring subject of legislative fights.

• Federal land and offshore leasing pace is set administratively but funded and overseen through Congress, making it a genuine (if secondary) midterm-sensitive variable for upstream E&P names
• Renewable tax credits (ITC/PTC) enacted in prior legislation carry multi-year phase-down schedules — a change in congressional control raises or lowers the odds those schedules get revisited
• Refining and midstream names (pipelines, storage) are the least politically sensitive corner of the sector, since permitting for already-approved infrastructure is less exposed to a single election cycle
• LNG export permitting has been a genuine point of legislative and administrative back-and-forth, and is worth watching as a midterm-adjacent swing factor for gas-levered names

Small-cap stocks (the Russell 2000) derive a much larger share of revenue from the U.S. domestic economy than large-caps, which get roughly 40% of S&P 500 revenue from overseas. That makes small caps a cleaner proxy for domestic fiscal and regulatory policy — corporate tax rates, small-business lending conditions, and deregulation — than large multinational stocks, whose earnings are driven at least as much by global growth and currency as by U.S. legislative outcomes.

Small caps are also the segment most sensitive to interest-rate policy, since a larger share carry floating-rate debt. That means the 2026 midterms are landing at a moment when small caps are already being driven primarily by the Fed's rate-cutting path — any post-election fiscal-policy clarity would layer on top of, not replace, that dominant rate-sensitivity story.

• Macro conditions (Fed policy, inflation, a growth scare) have repeatedly overwhelmed the election-cycle pattern in years like 2018 — don't treat the seasonal tendency as a standalone trading signal
• Polling and prediction markets have been wrong about individual midterm races before; positioning a portfolio around a specific predicted outcome carries real single-event risk
• Legislative gridlock cuts both ways — it also blocks fixes to expiring provisions (tax breaks, subsidy programs) that markets may have been counting on, not just blocking new risks
• Sector-level policy sensitivity is a probabilistic tilt, not a certainty — plenty of policy-sensitive stocks are simultaneously driven by earnings and industry fundamentals that matter more day-to-day than Washington

The historical pattern around midterm elections is real but narrow: elevated volatility and below-trend returns in the run-up to the vote, followed by a historically strong twelve months afterward, largely independent of which party wins. That pattern is about uncertainty resolution, not political preference, and it has held up across administrations of both parties.

The sector-level story is more useful than the index-level one. Healthcare and pharma carry the most direct legislative sensitivity through drug-pricing and subsidy policy. Energy's policy sensitivity runs through permitting and tax credits more than commodity prices. Defense is anchored more by the appropriations calendar than the election itself. Small caps are a domestic-policy proxy, but one currently dominated by the Fed's rate path rather than fiscal politics.

The most durable approach into any midterm cycle isn't predicting the outcome — it's understanding which of your holdings have genuine legislative exposure, sizing that exposure deliberately, and not letting near-term, headline-driven volatility around the vote itself override a longer-term thesis grounded in fundamentals.

Disclaimer: This article is for informational and educational purposes only and does not constitute financial or political advice. It does not endorse any candidate, party, or political outcome. Historical patterns are not guarantees of future performance. Always do your own research and consider consulting a licensed financial advisor before making investment decisions.

Read Next